Item 2.02 Results of Operations and Financial Condition.

On August 13, 2020, we issued a press release announcing our financial results for the first quarter ended June 30, 2020. A copy of the press release is attached hereto as Exhibit 99.1. The information in this Item 2.02 and the attached Exhibit 99.1 are being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and the attached exhibit shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.                                    Description

99.1          Press release issued by Regulus Therapeutics Inc. on August 13, 2020
            relating to financial results

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses